Health
In study of 30000 mild-to-moderate COVID-19 patients, antibody responses can persist for five months – EurekAlert
Researchers who studied antibody responses in 30,000 patients with mild-to-moderate COVID-19 report that the patients’ antibodies were relatively stable for at…
Researchers who studied antibody responses in 30,000 patients with mild-to-moderate COVID-19 report that the patients’ antibodies were relatively stable for at least five months. Although the results do not yet provide conclusive evidence that these levels protect from reinfection, Ania Wajnberg and colleagues say they “believe it is very likely that they will decrease the odds ratio of reinfection and may attenuate disease in the case of breakthrough infection.” As the number of daily COVID-19…
-
General24 hours agoOf saints and sinners | The Spectator Australia
-
Noosa News14 hours agoTully Sugar Mill celebrates 100 years of cane harvesting amid floods and cyclones
-
General24 hours agoChina and Philippines trade blame over latest South China Sea clash
-
Noosa News12 hours agoFlatmates of missing teen Pheobe Bishop, 17, identified